Societal problems come about through a combination of actions and oversights by all types of players — government, public agencies, businesses, non-profits and affected citizens. And they can only be solved through coordinated efforts amongst these same players.
Nicholas Brooke is founder and Executive Director of The Synergist, an incubator that brings key players together in people-public-private partnerships with the express aim of solving significant societal problems through collective action. Under Nicholas’ leadership, The Synergist acts as a backbone, providing vision, strategy, stakeholder alignment and execution on multiple international, multi-stakeholder programmes. As Patient Focused Medicine Development (PFMD.org) Executive Director, Nicholas develops collaborative leadership to build collective patient engagement across the lifecycle of medicine.
Nicholas was previously CEO of an award-winning digital agency, managing a team of 45 people providing cutting-edge digital strategy to global corporations across multiple sectors. His deep understanding of how digital can facilitate and accelerate collective action drove him to see the potential for an independent organisation that can enable partnerships and drive them to jointly solve societal challenges.
Working with key players from across the public-private spectrum, The Synergist currently manages five shared value programmes: The Pregnancy and Medicine Initiative, Break Dengue, The Alliance for Maternal Health Equality, Patient Focused Medicine Development and Safe Motherhood Week.
The Synergist runs programmes aimed at solving challenges which others ignore or have been unable to resolve. Our approach is a bit different. We’re not issue experts. We focus primarily on bringing the most important stakeholders together and building shared value, rather than trying to do it all ourselves. Given the complexity of the world we live in and the challenges we face, we’re convinced there is no better way.
The Patient Focused Medicines Development (PFMD) group, established in 2015, is an independent multinational coalition, managed in collaboration with The Synergist. Its goal is to bring together initiatives and best practices that integrate the voice of the patient throughout the lifecycle of medicines development, thereby speeding up the creation and implementation of an effective, globally standardized framework. PFMD seeks to have a balanced representation of stakeholders to ensure transparency, inclusiveness, and credibility. Stakeholders include patients and patient organizations across diverse areas of health and industry. We also intend to invite regulators, payers and other professional organizations to the global group to ensure diversity of perspectives.
Partnerships in Clinical Trials Europe Conference (PCT)
Patient Summit Europe
PE Open Forum
28th EURORDIS Round Table of Companies Workshop
Inaugural Roundtable Summit - Integrating Patient Engagement into Healthcare and Access to Medicines in the Asia Pacific Region
PFMD Board Meeting
EYEFORPHARMA BARCELEONA 2020
DIA 2019 Global Annual Meeting
Global Patient Advocacy in the COVID Era: What Is the Future of Patient Advocacy around the World?
What do stakeholders expect from patient engagement: Are these expectations being met? - Report
03 Sep 2018
Reasonable agreements between patient advocacy and the pharmaceutical industry - presentation
20 Nov 2018
Podcast: How to Make Patient Involvement Sustainable Throughout Medicines Development
13 Jan 2019
Co-creation of patient engagement quality guidance for medicines development: an international multistakeholder initiative
07 Mar 2019
Build a platform (PFMD.org) to allow the alliance of all parties to take a collaborative, open and non-competitive approach to make patient engagement a reality, solving together what nobody can solve on his own.Completed
I will work closely with PFMD patients and patient organisations members of PFMD, those of today and new ones, to understand what are the barriers they faceWork in progress
I will seek for opportunities to build on new communication tools or happening to allow patients an easier and equitable access to information, tools and rights they haveWork in progress